Abstract:Background and purpose:In early nineteen century, the relationship between diabetes mellitus(DM) and pancreatic cancer(PC) was recognized, until now it still remains a question whether DM is the cause or the consequence of PC. The study was to explore the relationship between DM and PC so it could help the early diagnosis of PC. Methods:The 83 cases of PC with and without DM were treated at our hospital during Dec, 2003-Feb, 2005 and were retrospectively reviewed. Among the diabetics, 13 patients of PC who were newly diagnosed DM or had advanced DM were matched with another 20 patients with type 2 diabetics(T2DM) in terms of age, BMI, diabetic family history and lab data.Results:Among 83 patients with PC, 35(42.17%) of them were accompanied by DM (DM group) and 48 had PC without DM (non-DM group). 24 (68.57%) patients had less than 2 years DM history, 8(22.86%)patients had more than 2 years DM history and the DM history for 3 patients was unknown. DM and PC were diagnosed at the same time for 14(40%) patients. The morbidity of hypertension in DM group was higher than one in non-DM group(45.71% vs. 25%, P0.05). ② The prevalence of abdominal pain((χ~ 2 =5.332,P0.01) and bad appetite((χ~ 2 =3.867,P0.01) was lower in DM group . ③And there was less abnormal direct bilirubin (DB)((χ~ 2 =23.46,P0.01) in DM group. ④There was no significant differences in terms of tumor location , metastasis, operation and life span between two groups. ⑤The patients of PC with DM were elder(68.93±10.62 vs. 55.6±11.14y, P0.01) and leaner (BMI 21.51±1.98 vs. 23.87 ±3.04 Kg/m~ 2 ,P0.05) in the comparison of 13 cases of PC with DM and 20 cases of T2DM.Conclusions:Clinically, PC is a progressive cancer. DM occurs frequently in patients with PC and does not influence its clinical feature and prognosis. For the elder, leaner patients with DM and having recently deterioration of blood sugar, PC should be screened.

Relationship between diabetes mellitus and benign prostatic hyperplasia

Knowledge, awareness, and behaviors of endocrinologists and dentists for the relationship between diabetes and periodontitis.

Relationship between metabolic syndrome and benign prostatic hyperplasia

Correlation of Diabetes Control with Benign Prostatic Hyperplasia in T2DM Patients

Relationship Between Benign Prostatic Hyperplasia and Metabolic Syndrome

The Study of the Relationship Between Diabetes Mellitus and Pancreatic Cancer

Association of Diabetes Mellitus with Prostate Cancer Grade and Prostate-Specific Antigen in Chinese Biopsy Population

The Association Between Insulin Resistance and Prostatic Hyperplasia

The Correlation Between Metabolic Syndrome and Benign Prostatic Hyperplasia in Men over 50 Years O1d

Analysis of platelet and monocyte-to-lymphocyte ratio and diabetes mellitus with benign prostatic enlargement

The Significance of Urodynamic Examination for Patients with Benign Pro-static Hyperplasia and Diabetes

High glucose promotes benign prostatic hyperplasia by downregulating PDK4 expression

The Relationship Between the Clinical Progression of Benign Prostatic Hyperplasia and Metabolic Syndrome: A Prospective Study

[Correlation of Benign Prostatic Hyperplasia with Hyperlipemia].

Association Study Between Benign Prostatic Hyperplasia and Primary Hypertension

Correlation Between Metabolic Syndrome and Clinical Progression in Patients with Benign Prostatic Hyperplasia

The Relationship Between Glucose Homeostasis Status and Prostate Size in Aging Chinese Males with Benign Prostatic Hyperplasia

Effects of Diabetes Mellitus and Metformin Administration on Prostate Cancer Detection at Biopsy among Chinese Men: a Case-Control Study.

Insulin exacerbated high glucose-induced epithelial-mesenchymal transition in prostatic epithelial cells BPH-1 and prostate cancer cells PC-3 via MEK/ERK signaling pathway

A Preliminary Study of the Impact of Insulin Resistance on the Growth of the Prostate in Patients with Benign Prostatic Hyperplasia

Poorly Controlled Diabetes Mellitus Increases the Risk of Deaths and Castration-Resistance in Locally Advanced Prostate Cancer Patients